Cite
Mahajan UM, Goni E, Langhoff E, et al. Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer. JNCI Cancer Spectr. 2019;4(1):pkz060doi: 10.1093/jncics/pkz060.
Mahajan, U. M., Goni, E., Langhoff, E., Li, Q., Costello, E., Greenhalf, W., Kruger, S., Ormanns, S., Halloran, C., Ganeh, P., Marron, M., Lämmerhirt, F., Zhao, Y., Beyer, G., Weiss, F. U., Sendler, M., Bruns, C. J., Kohlmann, T., Kirchner, T., Werner, J., D'Haese, J. G., von Bergwelt-Baildon, M., Heinemann, V., Neoptolemos, J. P., Büchler, M. W., Belka, C., Boeck, S., Lerch, M. M., & Mayerle, J. (2020). Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer. JNCI cancer spectrum, 4(1), pkz060. https://doi.org/10.1093/jncics/pkz060
Mahajan, Ujjwal M, et al. "Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer." JNCI cancer spectrum vol. 4,1 (2020): pkz060. doi: https://doi.org/10.1093/jncics/pkz060
Mahajan UM, Goni E, Langhoff E, Li Q, Costello E, Greenhalf W, Kruger S, Ormanns S, Halloran C, Ganeh P, Marron M, Lämmerhirt F, Zhao Y, Beyer G, Weiss FU, Sendler M, Bruns CJ, Kohlmann T, Kirchner T, Werner J, D'Haese JG, von Bergwelt-Baildon M, Heinemann V, Neoptolemos JP, Büchler MW, Belka C, Boeck S, Lerch MM, Mayerle J. Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer. JNCI Cancer Spectr. 2019 Aug 16;4(1):pkz060. doi: 10.1093/jncics/pkz060. eCollection 2020 Feb. PMID: 32296755; PMCID: PMC7050148.
Copy
Download .nbib